… has been examined, including bortezomib (BTZ). BTZ is a prototype proteasome inhibitor
that primarily targets the β5 subunit of the proteasome, thereby inhibiting the degradation of …

… by the proliferation of terminally differentiated antibody-producing plasma cells (PCs) [1,2]. …
bortezomib-induced proteasome inhibition and ER stress, and subsequent tumor cell death …

… Cardiotoxicity following treatment with proteasome inhibitors … differentiated toward
cardiomyocytes using small molecules or … reported that proteasome inhibitors such as bortezomib …

… Interestingly, a shorter treatment time of 8 h, however, was accompanied by … proteasome
inhibitor, Bortezomib, caused the upregulation of the tested anti-apoptotic proteins in both cell …

… Proteasome inhibitors, such as bortezomib and carfilzomib, … proteomic landscape after
proteasome inhibition. Based on … treatments, and the differential expression became significant …

… cells. DNA damage and mutations were also detected in cells treated with the proteasome
inhibitor bortezomib… classes stimulated caspase activation consistent with apoptotic cell death. …

… , may reflect differential … effect of HSP inhibitors and proteasome inhibitors[36]. Similar study
reporting inhibition of heat shock factor -1 has improved treatment efficiency of Bortezomib in …

… on the proteasome. Accordingly, we utilized the proteasome inhibitor Bortezomib which is
applied … Finally, differential expression analysis between the different cell lines and clones was …

… Using extracellular flux analysis, this study demonstrated that the proteasome inhibitor,
bortezomib, enhanced glycolysis while suppressing oxidative phosphorylation in the sensory …

… However, the molecular basis for these differential responses … 20S proteasome inhibitor
bortezomib, which was approved … the toxicity and limitation of bortezomib have been observed […